Recombinant Chimeric (human/mouse) monoclonal antibody expressed in CHO binding to Human EGFR. This is a novel EGFR antibody that selectively targets a tumor-selective epitope suggesting that a mAb 806-based therapeutic would retain antitumor activity without the on-target toxicities associated with EGFR inhibition.
Figure 1 ABT-806 is more potent than cetuximab at inhibiting EGFRvIII tumor growth and pEGFR expression.
Total and pEGFR status in SN0199 tumors were assessed following treatment of mice with ABT-806 at 40 mg/kg. Antibodies were administered Q3D×2, with tumors harvested 72 hour after the final dose.
Reilly, E. B., Phillips, A. C., Buchanan, F. G., Kingsbury, G., Zhang, Y., Meulbroek, J. A., ... & Gu, J. (2015). Characterization of ABT-806, a humanized tumor-specific anti-EGFR monoclonal antibody. Molecular cancer therapeutics, 14(5), 1141-1151.
Figure 2 ABT-806 downregulates tumor wild-type EGFR and pEGFR in SCC15 tumors grown as implants in mice.
IHC images of representative samples derived from harvested tumors 120 hours after treatment. IHC results were obtained by semiquantitative assessment of the
percent positive cells within viable areas across treatment groups at various time points.
Reilly, E. B., Phillips, A. C., Buchanan, F. G., Kingsbury, G., Zhang, Y., Meulbroek, J. A., ... & Gu, J. (2015). Characterization of ABT-806, a humanized tumor-specific anti-EGFR monoclonal antibody. Molecular cancer therapeutics, 14(5), 1141-1151.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-056 | Recombinant Anti-Mouse Egfr VHH Single Domain Antibody | ELISA, IHC, FC, FuncS | Llama VHH |
PNBL-016 | Recombinant Anti-Human EGFR VHH Single Domain Antibody (PNBL-016) | WB, ELISA | Llama VHH |
PNBL-017 | Recombinant Anti-Human EGFR VHH Single Domain Antibody (PNBL-017) | FuncS, ELISA, IF | Llama VHH |
PNBL-018 | Recombinant Anti-Human EGFR VHH Single Domain Antibody (PNBL-018) | FuncS, SPR | Llama VHH |
HPAB-AP881-YC | Recombinant Llama Anti-EGFR Single Domain Antibody (HPAB-AP881-YC) | ELISA, FC, IP, FuncS | Llama VHH |
There are currently no Customer reviews or questions for TAB-228CL. Click the button above to contact us or submit your feedback about this product.
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-228CL, RRID: AB_3111887)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.